Approved Pilot and Failed Pivotal Study [Study As­sess­ment]

posted by kumarnaidu – Mumbai, India, 2014-03-18 06:03 (4486 d 16:21 ago) – Posting: # 12642
Views: 20,920

Hi all,
In this case reference drug itself behaving as a variable drug. Also the inrasubject CV was also > 30%. According to me one should go for the replicate design (reference replicate)in pivotal study. Lets take other members opinion.

Kumar Naidu

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
371 visitors (0 registered, 371 guests [including 79 identified bots]).
Forum time: 23:24 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5